Clinical Trial Detail

NCT ID NCT01784640
Title Pemetrexed Disodium and Hsp90 Inhibitor AUY922 in Treating Patients With Previously Treated Stage IV Non-Small Cell Lung Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements yes
Sponsors Jonsson Comprehensive Cancer Center
Indications

non-small cell lung carcinoma

Therapies

Luminespib + Pemetrexed

Age Groups: adult

Additional content available in CKB BOOST